Financials
- Market Capitalization 213.6 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-1.44
売上高対価格比率
66.95
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3486 | ADCT ADC Therapeutics SA Common Shares | 1.71 USD | -1.16% | +47.41% | +59.81% | -61.31% | 218.31 M USD | ||
| 3487 | TRDA Entrada Therapeutics, Inc. - Common Stock | 5.69 USD | +0.35% | +8.80% | -16.32% | -18.36% | 221.55 M USD | ||
| 3508 | LYEL Lyell Immunopharma, Inc. - Common Stock | 8.71 USD | -0.91% | -6.04% | -27.23% | -63.99% | 213.44 M USD | ||
| 3509 | NAGE Niagen Bioscience, Inc. - Common Stock | 2.69 USD | +1.13% | -3.58% | -11.51% | -45.98% | 212.85 M USD |